{
  "docId": "019de073-b41a-7298-b152-a88168c594ee",
  "docSlug": "fcd1785019fd61535487d85f646654d9",
  "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 39 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Enochian BioSciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7744917,
  "pageNumber": 20,
  "pageCount": 39,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-b41a-7298-b152-a88168c594ee/20",
  "deckHref": "/decks/019de073-b41a-7298-b152-a88168c594ee",
  "deckJsonHref": "/decks/019de073-b41a-7298-b152-a88168c594ee.json",
  "deckAnchorHref": "/decks/019de073-b41a-7298-b152-a88168c594ee#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.165
      },
      "kind": "callout",
      "text": "Three Complementary Therapeutic Approaches: T-cell Vaccine, Allogeneic T-cell Therapy, & Gene Therapy",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6affe6f-a4cf-4821-ab8b-7d5e6daa175d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.06,
        "y": 0.4
      },
      "kind": "list",
      "text": "Engineered Allogeneic T-Cell Vaccine: ENOB-HV-12 (Enhances infiltration, killing, surveillance)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c5249ae-4d42-4689-a468-8e084c650be7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.36,
        "y": 0.4
      },
      "kind": "list",
      "text": "Allogeneic T-Cell Therapy: ENOB-HV-21 (HIV NK/GDT Treatment, Allogenicity, GDT reservoir/effector)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a54cd7a6-3c48-457a-a5b8-e2dd5fed9530",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.66,
        "y": 0.4
      },
      "kind": "list",
      "text": "Gene Therapy Autologous Transplant: ENOB-HV-01 (Gene conferring T-Cell resistance, engraftment advantage, CAR-T approach)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fbccf177-c07d-4d79-918b-a285650f2ec2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "HIV PIPELINES",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c11adaf4-9659-4809-b38a-a76dfa793c78",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "7b8997c3-7766-4195-93ea-9ecc08920fd7",
      "evidence": "The slide presents three bullet points listing the therapeutic approaches, making it a list presentation.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}